Herbalife Thailand Sponsors Academic Seminar

Food and Healthcare Press Releases Friday June 2, 2017 15:55
Bangkok--2 Jun--Francom Asia

Herbalife, a global nutrition company, in collaboration with the Department of Home Economics, Faculty of Agriculture, Kasetsart University, recently sponsored an academic seminar on the topic "Advances in Metabolic Syndrome". Over 140 participants comprising professors, lecturers and medical students attended this event.

Dr. Chin-Kun Wang, an expert in metabolism and nutrition, is a distinguished professor of the Chung Shan Medical University in Taiwan and member of the Herbalife Nutrition Advisory Board (NAB). He shared the latest research updates and data on Metabolic Syndrome - risk factors for heart disease, stroke and diabetes - in Southeast Asia. He also explained the role of well-balanced nutrition in combating obesity, and addressed health issues associated with the lack of physical activity, unbalanced diets, stressful conditions and other concerns linked with today's demanding lifestyle.

During the seminar, Associate Professor Dr. Sirichai Adisakwattana from Chulalongkorn University's Faculty of Allied Health Sciences, also discussed the prevalence of Metabolic Syndrome in Thai children and adults, and its correlation with obesity and overweight. He shared updates on the government's health policies and strategies such as establishing the Food Innopolis at Thailand Science Park, which is an institution that focuses on research, development and innovation for the food industry.

The most recent data from Thailand's Ministry of Public Health (MOPH) revealed that around 17.4 million Thais (26% of the population) were considered overweight, and that there are twice as many obese women than men. The country is among the top five in Asia-Pacific with the highest numbers of cases of obesity. Moreover, the prevalence of Metabolic Syndrome among Thais aged 15 years and over was 32.1% (16.1 million) overall; 18.6% for men and 45% for women.


Latest Press Release

ESMO Publishes New Position Paper on Supportive and Palliative Care

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757 ], calling attention to the evolving and growing gap between the needs of cancer...

Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTEC

The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies,...

MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Smartphones

MediaTek Inc. today unveiled MediaTek Sensio(TM), the first 6-in-1 smartphone biosensor module. MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral...

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United...

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2...

Related Topics